SDIP Innovations

Executive Summary

SDIP Innovations is an Australian med-tech company advancing JAZBI™, a novel bioresorbable implant and scaffold platform for orthopedic and dental bone regeneration. The platform combines predictable resorption, high structural strength, and cost advantages over metallic, ceramic, and existing bioresorbable devices. Founded in 2018 and currently in the preclinical stage, the company has raised $650K to support initial development. Its technology addresses key limitations of current bone graft substitutes, offering potential for faster patient recovery and reduced complication rates. With a strong IP position and a focus on large orthopedic and dental markets, SDIP Innovations is positioned for growth as it moves toward first-in-human studies. However, as a preclinical, private company with limited capital, execution risk remains significant. The management's ability to secure additional funding and validate the technology in vivo will be critical to near-term success.

Upcoming Catalysts (preview)

• Q4 2026Completion of preclinical in vivo studies demonstrating safety and efficacy60% success
• 2027Strategic partnership or licensing agreement with orthopedic device manufacturer40% success
• H1 2027Series A financing round to support first-in-human trials50% success